University of Helsinki
- Country
- 🇫🇮Finland
- Ownership
- Private
- Established
- 1640-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.helsinki.fi
Clinical Trials
125
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (93 trials with phase data)• Click on a phase to view related trials
NutFinForce: The Impact of Digitally Delivered Lifestyle Performance Medicine Intervention on Defense Performance in Finland
- Conditions
- No Condition
- First Posted Date
- 2025-01-29
- Last Posted Date
- 2025-01-29
- Lead Sponsor
- University of Helsinki
- Target Recruit Count
- 5000
- Registration Number
- NCT06799988
- Locations
- 🇫🇮
University of Helsinki, Helsinki, Finland
Accuracy of EEG Slow Wave Activity in Predicting Favourable Outcome in Patients With Hypoxic Brain Injury - A Substudy of STEPCARE Trial
- Conditions
- Out-Of-Hospital Cardiac Arrest
- First Posted Date
- 2024-08-21
- Last Posted Date
- 2024-08-28
- Lead Sponsor
- University of Helsinki
- Target Recruit Count
- 300
- Registration Number
- NCT06564675
- Locations
- 🇫🇮
Helsinki University Hospital, Helsinki, Finland
🇫🇮Kuopio University Hospital, Kuopio, Finland
🇫🇮Tampere University Hospital, Tampere, Finland
Interventions for the Wellbeing of Students at the University of Helsinki
- Conditions
- Well-Being, Psychological
- First Posted Date
- 2024-08-07
- Last Posted Date
- 2024-08-16
- Lead Sponsor
- University of Helsinki
- Target Recruit Count
- 600
- Registration Number
- NCT06542029
- Locations
- 🇫🇮
University of Helsinki, Helsinki, Uusimaa, Finland
Orthodontic Screening in Public Healthcare
- Conditions
- MalocclusionCompliance, Patient
- First Posted Date
- 2024-06-18
- Last Posted Date
- 2025-07-08
- Lead Sponsor
- University of Helsinki
- Target Recruit Count
- 350
- Registration Number
- NCT06464003
- Locations
- 🇫🇮
University of Helsinki, Helsinki, Finland
🇫🇮Vantaa and Kerava wellbeing services county, Vantaa, Finland
HFPEF-project: Heart Failure Phenotyping - Exploring the Fingerprints
- Conditions
- Heart Failure with Preserved Ejection Fraction
- First Posted Date
- 2024-06-18
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- University of Helsinki
- Target Recruit Count
- 300
- Registration Number
- NCT06465043
- Locations
- 🇫🇮
Helsinki University Hospital, Helsinki, Finland
- Prev
- 1
- 2
- 3
- 4
- 5
- 25
- Next
News
Drug Sensitivity Testing Personalizes AML Treatment and Improves Outcomes
A Finnish study demonstrates that drug sensitivity testing can identify acute myeloid leukemia (AML) patients likely to benefit from venetoclax and azacitidine, improving treatment outcomes.